Pre-clinical targeting of PI3K/Akt/mTOR and RAF/MEK/ERK signaling pathwa...

StartKonkursyPre-clinical targeting of P...

Pre-clinical targeting of PI3K/Akt/mTOR and RAF/MEK/ERK signaling pathways in adrenocortical cancer: impact on steroidogenesis, cell proliferation and apoptosis

19.11.2012


Jak dojechać?

Zobacz kampus